Intraoperative Optical Coherence Tomography for Ophthalmic Surgical Guidance - Cornea

Launched by VANDERBILT UNIVERSITY MEDICAL CENTER · Jan 13, 2022

Keywords

ClinConnect Summary

This clinical trial is looking at a new imaging technology called Optical Coherence Tomography (OCT) to help doctors during corneal transplant surgeries. The goal is to improve the way images of the eye are captured and analyzed, making it easier for surgeons to see and detect any issues related to eye health. By testing different ways to process these images, researchers hope to enhance the sensitivity of detecting problems that could affect the success of the surgery.

To participate in this trial, you need to be an adult over 18 years old who has been diagnosed with a corneal transplant (also known as keratoplasty). Unfortunately, children and healthy adults without this specific eye condition are not eligible to join. If you qualify and decide to take part, you can expect to help researchers gather important data that could ultimately lead to better surgical outcomes for future patients. It's important to know that this trial is not yet recruiting participants, so there will be a waiting period before it officially begins.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Adults (\>18 years) with diagnosis of cornea transplant (keratoplasty)
• Exclusion Criteria:
• • Children or adults unable to consent
• • Healthy adults (\>18 years) without diagnosis of cornea transplant (keratoplasty)